ATEN vs GSK · P/E 50, rev $155.1M vs P/E 13, $103.31B cap
A10 Network (ATEN) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
A10 Network (ATEN) is a software - infrastructure company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported ATEN revenue for 2026-06-30 was $155.1M. Net income was $20.9M. ATEN currently screens at market cap $2.20B and trailing P/E 50.1.
GSK does not have a complete income-statement cache yet.
ATEN currently screens at market cap $2.20B and trailing P/E 50.1. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the ATEN and GSK stock pages for the full models.
Not investment advice.